Drugs / BCG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03664869 | Oct 2018 → Nov 2025 | urinary bladder cancer | Turku University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03664869 ↗ |
| Modality | Other / unclassified | “BCG is a solution of live, attenuated mycobacterium bovis bacteria” NCT03664869 ↗ |